Experts Teach on Anticoagulant and Antiplatelet Update. Aspirin is now used to prevent and treat cardiovascular disease due to its antithrombotic effects. It even prevents cancer! Our understanding of Aspirin and it’s benefits and harms has advanced tremendously in recent years. We also have several new antiplatelet and anticoagulant options.
To share the latest research and guidelines for using anticoagulant and antiplatelet agents, We’ve invited two of Ohio State University’s Pharmacology experts. We are pleased to introduce Doctor of Pharmacy Alyssa Rinaldi who is the Outpatient Anticoagulation Clinic lead & Danielle Blais who is a Doctor of Pharmacy and Lead Specialty Practice Pharmacist of OSU Cardiology.
What you’ll learn in this webcast
As a result of this educational activity, webcast participants will be able to:
- Re-assess historical “gray areas” for DOAC use including in obesity, mechanical heart vales, antiphospholipid syndrome (APS) mechanical heart valves, and treatment of left ventricular (LV) thrombus
- Explore the anticoagulation pipeline including Factor XI inhibitors
- Describe the role of aspirin and oral P2Y12 inhibitors for patients with chronic coronary disease or acute coronary syndromes with or without percutaneous coronary intervention
- Evaluate the advantages and disadvantages of the different P2Y12
inhibitors
You’ll also learn about the following:
- Single Antiplatelet Therapy
- Pre-procedure Medication recommendations
You can find this and many other MedNet21 programs on the OSU – CCME website.
Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.